1. Risk: AI Monoculture (Shared Blind Spots). This is the most critical and overlooked systemic vulnerability. Building your ...
Recursion Pharmaceuticals, Inc. is rated a Sell due to cash burn, Q3 net loss of $162.25M and operational trends. Learn more ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
Forbes contributors publish independent expert analyses and insights. We set an example for a better future via education and research. The possible shift back to entirely in-person work has sparked a ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...
The popular skincare product is said to help with acne, wrinkles, and dark spots. Here's what the science says. By Clarissa Brincat Published Sep 2, 2025 9:00 AM EDT Image: DepositPhotos Get the ...
The error message is really bad, because we don't show it in the VS Code extension. Error: Unexpected error: File "plugin/syntax_extension/PulseSyntaxExtension ...
Jake Goldenfein receives funding from the Australian Research Council Centre of Excellence for Automated Decision-Making and Society (ADM+S). This research was conducted with assistance from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback